On-demand webinar

The GP role in making naloxone more accessible to patients

Members login for free access About RACGP online events

Details

Type: On-demand
Recorded: 17 Jun 2020

Contact

For more information:
Email: RACGP NSW&ACT Events
Call: 02 9886 4707

Price

RACGP Members: FREE
Non-Members: FREE

Watch now

The GP role in making naloxone more accessible to patients

On-demand recorded 17 Jun 2020

The number of opioid related deaths in Australia has been steadily increasing over the past 17 years. Take home naloxone is an effective intervention for preventing opioid overdose morbidity and mortality. GPs are a highly trusted source of health information and well-placed to discuss the risks of overdose from opioids (including pharmaceutical opioids); how to reduce risk factors; and how to reverse an overdose with naloxone. The COVID-19 pandemic further increases the need for community access to naloxone, due to changes in health behaviours and access to opioid drugs.

Learning outcomes

Discuss the value of naloxone for patients at risk of witnessing or experiencing opioid overdose.
Be aware of the epidemiology of opioid overdose mortality in Australia and the role of GPs in reducing overdose harm.
Be aware of Take Home Naloxone programs in NSW, and how GPs can encourage patients at risk of witnessing or experiencing opioid overdose to obtain a free supply of naloxone supply.
Recount the elements of an effective naloxone education intervention for relevant patients including opioid overdose prevention, identification and emergency response, including administration of naloxone.

Create Quick log

Facilitator

Dr Tim Senior
MBBS, FRACGP

Dr Tim Senior is a GP at the Tharawal Aboriginal Corporation in South West Sydney. He is Medical Advisor to the RACGP in Aboriginal and Torres Strait Islander Health and is a clinical senior lecturer in general practice and Indigenous Health at the University of Western Sydney.

Presenter

Dr Hester Wilson
BMed(Hons) FRACGP FAChAM MMH

Dr Wilson is a GP, Chief Addiction Specialist for NSW Health, Clinical Director for Murrumbidgee Drug and Alcohol and Clinical Advisor to Population and Community Health in South East Sydney LHD. She is chair of the RACGP Addiction Special Interest Group, a clinician with many years clinical and teaching experience, she is currently undertaking a PhD focused on GPs’ experience of patients with chronic pain and prescription opioid use disorder.

Advertising